During the past decade, Asheville Eye Associates conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 2 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Asheville Eye Associates" #1 sponsor was "Kodiak Sciences Inc" with 2 trials, followed by "Santen Inc." with 2 trials sponsored, "Allergan" with 1 trials sponsored, "Bayer" with 1 trials sponsored and "VisionCare, Inc." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Asheville Eye Associates" #1 collaborator was "ORA, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Asheville Eye Associates" are "Glaucoma and Ocular Hypertension" (2 trials), "Age-Related Macular Degeneration" (1 trials), "Anterior Ischemic Optic Neuropathy" (1 trials), "Diabetic Macular Edema" (1 trials) and "Geographic Atrophy" (1 trials). Many other conditions were trialed in "Asheville Eye Associates" in a lesser frequency.

Most popular intervention types in "Asheville Eye Associates" are "Drug" (6 trials), "Other" (2 trials), "Device" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Aflibercept" (2 trials), "DE-117 Ophthalmic Solution" (2 trials), "KSI-301" (2 trials), "Sham Procedure" (2 trials) and "Timolol Maleate Ophthalmic Solution 0.5%" (2 trials). Other intervention names were less common.

The vast majority of trials in "Asheville Eye Associates" are 6 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Asheville Eye Associates". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Asheville Eye Associates, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Asheville Eye Associates, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".